Page last updated: 2024-10-26

felodipine and Bone Loss, Perimenopausal

felodipine has been researched along with Bone Loss, Perimenopausal in 1 studies

Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.

Research Excerpts

ExcerptRelevanceReference
"Postmenopausal osteoporosis is one of the most common types of osteoporosis resulting from estrogen deficiency in elderly women."1.56Felodipine blocks osteoclast differentiation and ameliorates estrogen-dependent bone loss in mice by modulating p38 signaling pathway. ( Huo, S; Li, H; Nie, B; Qu, X; Tang, H; Yue, B; Zhang, S, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhang, S1
Li, H1
Tang, H1
Huo, S1
Nie, B1
Qu, X1
Yue, B1

Other Studies

1 other study available for felodipine and Bone Loss, Perimenopausal

ArticleYear
Felodipine blocks osteoclast differentiation and ameliorates estrogen-dependent bone loss in mice by modulating p38 signaling pathway.
    Experimental cell research, 2020, 02-15, Volume: 387, Issue:2

    Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Cell Differentiation; Disease Models, Animal; Es

2020